Symptom control and impact on daily life in patients with gastroesophageal reflux disease
Study identifier:NIS-GBG-XXX-2011/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A prospective, observational study to describe symptom control and impact on daily life in patients with gastroesophageal reflux disease (GERD)
Medical condition
Gastroesophageal Reflux Disease
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
1000
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Sept 2011
Primary Completion Date: 01 Apr 2012
Study Completion Date: 01 Apr 2012
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 | - |
